Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(3):164-174
The COVID-19 epidemic caused by the human coronovirus has led to completely new challenges for clinical pharmacology, and the healthcare system as a whole. By the time the infection started, there was no effective and safe therapy. In this regard, at …